Zhao, Weixin
Song, Ailing
Xu, Yang
Wu, Qian
Liu, Cuicui
Yin, Jiani C.
Ou, Qiuxiang
Wu, Xue
Shao, Yang
Zhao, Xinmin
Funding for this research was provided by:
National Natural Science (81302009)
Article History
Received: 14 June 2022
Accepted: 2 February 2023
First Online: 24 February 2023
Declarations
:
: This study was approved by the Ethics Committee of the Fudan University Shanghai Cancer Center, Shanghai Cancer Center Institutional Review Board (SCCIRB), and in accordance with the Declaration of Helsinki (ethics approval number: 2004216–19-2005). Informed consent was obtained from all the participating patients. All patients provided written informed consent to participate and publication.
: Not applicable.
: YX, QW, CL, JCY, QO, XW, and YS are employees of Nanjing Geneseeq Technology Inc. All the remaining authors declare that they have no competing interests.